Drugmakers are launching new medicines at record-high prices this year, a Reuters analysis has found, highlighting their pricing power even as Congress moves to cut the $500 billion-plus annual bill for prescription drugs in the United States.
https://www.pharmalive.com/wp-content/uploads/2021/08/Biden-to-urge-Congress-to-lower-prescription-drug-costs-Reuters-8-12-21.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-08-15 06:00:542022-08-15 10:31:07Newly launched U.S. drugs head toward record-high prices in 2022